FASLG and diabetes mellitus: Activated B cells expressing FasL and TGFβ have been reported to delay the onset of diabetes in non-obese diabetic (NOD) mice, and the frequency of FasL+ B cells is reduced in mice with severe autoimmune arthritis relative to those with mild or no arthritis (14, 15).